Dr. Jean Kaseya, Director-General of the Africa Centres for Disease Control and Prevention (Africa CDC), has urged African nations to significantly increase local vaccine and pharmaceutical manufacturing. He also called for evidence-based responses to Ebola outbreaks. This directive aims to reduce Africa's reliance on external suppliers for critical medical products and public health interventions.
Speaking at a press briefing during the African Union Summit on Tuesday, July 21, Dr. Kaseya highlighted the success of science-driven responses in countries like Uganda and the Democratic Republic of Congo (DRC). He stressed that Africa's public health stance is guided by scientific evidence, not fear. This approach is crucial for building community trust and strengthening public health systems across the continent.
This initiative aligns with Ghana's broader economic strategy to diversify its industrial base and enhance self-sufficiency in key sectors. Increased local production of vaccines and pharmaceuticals could create new jobs, attract foreign investment, and improve healthcare access for millions. It also reduces the financial burden of importing medical supplies, freeing up GHS for other development projects.
Dr. Kaseya questioned why African countries are not doing more to support products manufactured within the continent. He specifically asked, “Why are we not buying Algerian products, Nigerian products, Egyptian products and others for the continent? Why are we not supporting manufacturing in Ghana and other places?” This statement underscores the need for a predictable market and robust regulatory systems to foster intra-African trade in medical goods.
The Africa CDC Director-General expressed confidence that by December 2026, Africa will be much stronger in confronting Ebola outbreaks. This improved capacity will lessen the continent's dependence on international aid. Discussions are ongoing to create a predictable market, strengthen regulatory systems through the African Medicines Agency, and improve domestic financing for health and manufacturing.
Dr. Kaseya also warned against the dangers of misinformation and lack of trust during disease outbreaks. He noted that some people avoid testing due to fear or distrust of results. He stated, “When people do not believe the results, they do not come for testing. It is time to involve community members.” Public education and community engagement are essential tools for effective disease control.
Ghana's Ministry of Health recently dismissed false claims of thousands of Ebola cases in the country. The Ministry confirmed that Ghana has not detected any Ebola cases and maintains fully operational disease surveillance systems. This demonstrates Ghana's commitment to accurate public health reporting and proactive disease management.
Investing in local manufacturing capacity and regional procurement systems is vital for Africa to reduce its dependence on external suppliers. This includes strengthening public finance management to allocate sufficient resources to the health sector. The push for local production is a strategic move towards greater health security and economic resilience for Ghana and the wider African continent.
The implications for Ghana are significant. A robust local pharmaceutical industry could position Ghana as a regional hub for medical manufacturing. This would attract skilled labor and boost economic growth. It would also enhance Ghana's preparedness for future health crises, ensuring timely access to essential medicines and vaccines.